Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ProLung

Financiado

Cerrado

The role of maternal microbiota in offspring lung development and function

In early life, interactions between our microbiota and our bodies are key elements to health and disease prevention. While it is known that microbiota drives development of the gut mucosa, it is unknown which influence microbiota... ver más

31/12/2020

UCPH

212K€

Presupuesto del proyecto: 212K€

Líder del proyecto

KOBENHAVNS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-12-31

MSCA-IF-2017: Individual Fellowships

I+D

Cerrada hace 7 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

UCPH

212.19K€ | Lider

Proyectos interesantes

FJC2018-035861-I

Medical Technol...

Microbiology

50K€ Cerrado

DaPhNIs

Medical Technol...

Immunology

168K€ Cerrado

MICROBIOTA-NEONATE

Medical Technol...

Immunology

199K€ Cerrado

AGL2010-15420

Medical Technol...

Microbiology

289K€ Cerrado

MEMORIS

Medical Technol...

Immunology

187K€ Cerrado

MAMI

Medical Technol...

Public Health

1M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 33 meses Fecha Inicio: 2018-03-14
Fecha Fin: 2020-12-31

Líder del proyecto

KOBENHAVNS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 212K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto In early life, interactions between our microbiota and our bodies are key elements to health and disease prevention. While it is known that microbiota drives development of the gut mucosa, it is unknown which influence microbiota has on the development of the lung in early life. I have recently discovered large biologically and statistically significant effects between maternal probiotic treatment during pregnancy, maternal gut microbiota changes and alveolar development in mouse offspring. This type of effect has never been shown before and modulation of microbiota with probiotic bacteria thus appears to support lung development and could possibly intercept lung diseases. With ProLung, I want to reveal the mechanisms behind this effect on lung development. I will do that by determining; the timing of the effect, which microbiota is more important and what genes are differently regulated in dams and their pups. I will show causation by transferring microbiota and phenotype to germ-free mice. Finally, as a proof of concept, I will develop and employ an oxygen driven disease model of infant lung dysplasia and show if modulation of microbiota can enhance breathing and could be used to intercept this early life lung disease. The proposed ProLung action will be conducted under world-class supervision at University of Copenhagen, Denmark with strong partners, in a highly cross disciplinary international collaboration with University of Oxford (UK), University of Michigan (US) and co-funded by the world second largest chemical company Dupont. I have a unique background and track record suited to perform the proposed research. Furthermore the action will allow me to pursue several training objectives that will be instrumental for my future career in the cross-section between academia and industry.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores